home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Neon Therapeutics Reports Third Quarter 2019 Financial Results and Recent Highlights
Neon Therapeutics Reports Third Quarter 2019 Financial Results and Recent Highlights
Post navigation
Previous Post
Previous
Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of TPX-0046, a Novel RET/SRC Inhibitor
Next Post
Next
Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of Repotrectinib in Pediatric Patients